The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $5.4 in the prior trading day, Psyence Biomedical Ltd (NASDAQ: PBM) closed at $5.03, down -6.85%. In other words, the price has decreased by -$6.85 from its previous closing price. On the day, 36.97 million shares were traded. PBM stock price reached its highest trading level at $9.5 during the session, while it also had its lowest trading level at $4.8.
Ratios:
Our goal is to gain a better understanding of PBM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.64 and its Current Ratio is at 0.64.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 3587557 and an Enterprise Value of -5776678.
Stock Price History:
The Beta on a monthly basis for PBM is 0.23, which has changed by -0.9847576 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $364.63, while it has fallen to a 52-week low of $2.92. The 50-Day Moving Average of the stock is -8.22%, while the 200-Day Moving Average is calculated to be -66.42%.
Shares Statistics:
The stock has traded on average 123.11K shares per day over the past 3-months and 3865990 shares per day over the last 10 days, according to various share statistics. Insiders hold about 0.00% of the company’s shares, while institutions hold 46.56% stake in the company. Shares short for PBM as of 1752537600 were 12872 with a Short Ratio of 0.10, compared to 1749772800 on 15310. Therefore, it implies a Short% of Shares Outstanding of 12872 and a Short% of Float of 1.83.
